Survival after radical prostatectomy

JAMA

Volumn 278, Issue 1, 1997, Pages 44-46

  Krongrad, Arnon ^a,b,c   Lai, Hong ^a   Lai, Shenghan ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0031006291     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.278.1.44     Document Type: Article

References (18)

1. Gerber GS, Thisted RA, Scardino PT, et al. Results of radical prostatectomy in men with clinically localized prostate cancer. JAMA. 1996;276:615-619.
2. Lerner SE, Blute ML, Zincke H. Extended experience with radical prostatectomy for clinical stage T3 prostate cancer. J Urol. 1995;154:1447-1452.
3. Riley G, Lubitz J. Outcomes of surgery among the medicare aged: surgical volume and mortality. Health Care Financ Rev. 1985;7:37-47.
4. Wennberg JE, Roos N, Sola L, Schori A, Jaffe R. Use of claims data systems to evaluate health care outcomes: mortality and reoperation following prostatectomy. JAMA. 1987;257:933-936.
5. Krongrad A, Lai H, Lamm SH, Lai S. Mortality in prostate cancer. J Urol. 1996;156:1084-1091.
6. Helgesen F, Holmberg L, Johansson J-E, Bergstrom R, Adami H-O. Trends in prostate cancer survival in Sweden, 1960 through 1988. J Natl Cancer Inst. 1996;88:1216-1222.
7. Gilliland FD, Hunt WC, Key CR. Improving survival for patients with prostate cancer diagnosed in the prostate-specific antigen era. Urology. 1996;48: 67-71.
8. Hsing AW, Devesa SS. Prostate cancer mortality in the United States by cohort year of birth, 1865-1940. Cancer Epidemiol Biomarkers Prev. 1994;3:527-530.
9. Lu-Yao GL, McLerran D, Wasson J, Wennberg JE. An assessment of radical prostatectomy. JAMA. 1993;269:2633-2636.
10. Walsh PC, Donker PJ. Impotence following radical prostatectomy. J Urol. 1982;128:492-497.
11. Krongrad A, Clark LC, Lai H, Soloway MS, Lai S. Redistribution of age-specific prostate cancer stage at diagnosis. Dis Manage Clin Outcomes. In press.
12. Cox DR. Regression models and life tables (with discussion). J R Stat Soc B. 1972;34:187-220.
13. Kalbfleisch DJ, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley & Sons Inc, 1980.
14. Krongrad A, Kim CO, Burke MA, Granville LJ. Not all patients pursue prostate biopsy after abnormal prostate specific antigen results. Urol Oncol. 1996;2:35-39.
15. Bennett CL, Greenfield SH, Aronow H, Ganz P, Vogelzang NJ, Elashoff RM. Patterns of care related to age of men with prostate cancer. Cancer. 1991;67:2633-41.
16. Krongrad A, Lai H, Lai S. Competing risks of mortality in prostate cancer. J Urol. In press.
17. Schellhammer P, Cockett A, Boccon-Gibod L, et al. Assessment of endpoints for clinical trials for localized prostate cancer. Urology. 1997;49(suppl):27-38.
18. Fryback DG, Albertsen PC, Storer BE. Prostatectomy and survival among men with clinically localized prostate cancer. JAMA. 1996;276:1723-1724.